Concepedia

Daniel F. Hassler

DF

11

Publications

2.5K

Citations

10

H-Index

1997

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (Japan)

Daniel F. Hassler is an author at Research Triangle Park Foundation specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1997–2009

11

Publications

11

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

Marcia L. Moss, S.-L. Catherine Jin, Marcos E. Milla et al. · Nature · 1997 · 1.6K citations

, , +8

Inhibition of Tumor Necrosis Factor-induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase

Chiara Luberto, Daniel F. Hassler, Paola Signorelli et al. · Journal of Biological Chemistry · 2002 · 325 citations · Full text

<i>In vitro</i> biological activity of a novel small-molecule inhibitor of polo-like kinase 1

Timothy J. Lansing, Randy T. McConnell, Derek R. Duckett et al. · Molecular Cancer Therapeutics · 2007 · 139 citations · Full text

Distinct Concentration-Dependent Effects of the Polo-like Kinase 1–Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis

Aidan G. Gilmartin, Maureen R. Bleam, Mark C. Richter et al. · Cancer Research · 2009 · 131 citations · Full text

Purification and Characterization of a Membrane Bound Neutral pH Optimum Magnesium-dependent and Phosphatidylserine-stimulated Sphingomyelinase from Rat Brain

Bin Liu, Daniel F. Hassler, Gary K. Smith et al. · Journal of Biological Chemistry · 1998 · 115 citations · Full text

Rows per page

1–5 of 11